Latest News and Press Releases
Want to stay updated on the latest news?
-
BRISBANE, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
AlloSure launch momentum drives 21% revenue growth Further expands product offerings for transplant patients BRISBANE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a...
-
BRISBANE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CareDx (NASDAQ:CDNA), today announced that, as reported in its Current Report on Form 8-K filed with the Securities Exchange Commission on May 8,...
-
BRISBANE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically...